Wilmington, DE -- (SBWIRE) -- 02/07/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding MannKind Corp. (NASDAQ:MNKD) and Medidata Solutions, Inc. (NASDAQ:MDSO).
MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States is currently up (+4.66%) on 4,310,897 shares traded after MannKind Corporation Announced to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on February 18, 2014. MannKind Corp. (NASDAQ:MNKD) is currently up (+127.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)
Medidata Solutions, Inc. (NASDAQ:MDSO) a company that provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally is currently down (-2.53%) on 2,210,474 shares traded after Medidata Reported Record Full Year and Fourth Quarter 2013 Results. Medidata Solutions, Inc. (NASDAQ:MDSO) is currently down (-24.68%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Medidata Solutions, Inc. (NASDAQ:MDSO)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report